The power of IMPS in psychiatric drug research: as a function of sample size, number of raters, and choice of treatment comparison.
作者信息
Derogatis L R, Bonato R R, Yang K C
出版信息
Arch Gen Psychiatry. 1968 Dec;19(6):689-99. doi: 10.1001/archpsyc.1968.01740120049008.
Abstract
摘要
相似文献
1
The power of IMPS in psychiatric drug research: as a function of sample size, number of raters, and choice of treatment comparison.IMPS在精神科药物研究中的效能：作为样本量、评估者数量及治疗对照选择的函数
Arch Gen Psychiatry. 1968 Dec;19(6):689-99. doi: 10.1001/archpsyc.1968.01740120049008.
2
A comparison of mesoridazine and chlorpromazine in chronic psychiatric patients.美索达嗪与氯丙嗪治疗慢性精神病患者的比较。
J Clin Pharmacol J New Drugs. 1969 May-Jun;9(3):176-82.
3
Thiothixene and the thioxanthenes.硫利达嗪与硫杂蒽类药物。
Adv Biochem Psychopharmacol. 1974;9(0):481-6.
4
The WPRS: a quantification of observable psychopathology.WPRS：可观察到的精神病理学的一种量化方法。
Mod Probl Pharmacopsychiatry. 1974;7(0):33-49. doi: 10.1159/000395066.
5
factors influencing response to major tranquilizer medications.影响对主要镇静药物反应的因素。
Dis Nerv Syst. 1972 Apr;33(4):223-30.
6
[Research on pharmacodynamic reinforcement of neuroleptics by the 1035 M.D].
Encephale. 1970 May-Jun;59(3):278-88.
7
Comprehesiven clinical studies with thiothixene.关于硫利达嗪的全面临床研究。
Dis Nerv Syst. 1975 Sep;36(9):473-7.
8
Using Psychiatric Rating Scales in Clinical Trials: A Proposal.
J Clin Psychopharmacol. 2020 Sep/Oct;40(5):433-435. doi: 10.1097/JCP.0000000000001220.
9
Liquid butaperazine in the treatment of chronic psychosis in a mental health clinic.液态丁酰拉嗪在一家心理健康诊所治疗慢性精神病中的应用
Curr Ther Res Clin Exp. 1969 Feb;11(2):57-63.
10
Studies on the effectiveness of antidepressant drugs.抗抑郁药物疗效的研究。
Psychopharmacol Bull. 1969 Mar:Suppl:1-53.
引用本文的文献
1
When can 'non significantly different' treatments be considered as 'equivalent'?何时可以将“无显著差异”的治疗视为“等效”？
Br J Clin Pharmacol. 1979 Jun;7(6):623-4. doi: 10.1111/j.1365-2125.1979.tb04653.x.
2
Intensive design in evaluating anxiolytic agents.
Psychopharmacology (Berl). 1977 Mar 23;52(1):79-85. doi: 10.1007/BF00426604.
Zotero 插件